3B's Research Group - Biomaterials, Biodegradables and Biomimetics, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Zona Indústrial da Gandra, 4806-909 Caldas das Taipas, Guimarães, Portugal.
Macromol Biosci. 2013 Apr;13(4):444-54. doi: 10.1002/mabi.201200372. Epub 2013 Jan 28.
Recombinant 6mer + BSP protein, combining six repeats of the consensus sequence for Nephila clavipes dragline (6mer) and bone sialoprotein sequence (BSP), shows good support for cell viability and induces the nucleation of hydroxyapatite and tricalcium phosphate during osteoblast in vitro culture. The present study is conducted to characterize this bioengineered protein-based biomaterial further for in vivo behavior related to biocompatibility. 6mer + BSP protein films are implanted in subcutaneous pouches in the back of mice and responses are evaluated by flow cytometry and histology. The results show no major differences between the inflammatory responses induced by 6mer + BSP films and the responses observed for the controls. Thus, this new chimeric protein could represent an alternative for bone regeneration applications.
重组 6mer+BSP 蛋白,结合了 Nephila clavipes 拖丝(6mer)和骨涎蛋白序列(BSP)的共识序列的六个重复,对细胞活力有很好的支持作用,并在成骨细胞体外培养过程中诱导羟基磷灰石和磷酸三钙的成核。本研究旨在进一步表征这种基于生物工程蛋白的生物材料,以研究与生物相容性相关的体内行为。将 6mer+BSP 蛋白膜植入小鼠背部的皮下囊中,并通过流式细胞术和组织学评估反应。结果表明,6mer+BSP 膜诱导的炎症反应与对照组观察到的反应之间没有明显差异。因此,这种新的嵌合蛋白可能代表了骨再生应用的一种替代方法。